Red cell distribution width as a new prognostic biomarker in refractory chronic graft- versus-host disease

Affiliations

• ¹ Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD 20892.
• ² Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
• ³ Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892.
• ⁴ Outcomes Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, 20850.
• ⁵ Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
• ⁶ Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD 20892. pavletis@mail.nih.gov.